Clinical Trials
2 trialsNCT07308106 2026-05-11
A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2 Recruiting
NCT07199010 2025-09-30
Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression
Innovent Biologics (Suzhou) Co. Ltd.
Not yet recruiting